Lung Cancer News and Research

Latest Lung Cancer News and Research

Graphene could hold key to unlock next generation of early lung cancer diagnosis

The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.

4 Feb 2019

Russian researchers create intelligent software system for lung cancer diagnostics

Researches from Peter the Great St.Petersburg Polytechnic University, Russian Academic Excellence Initiative participant, in collaboration with the radiologists from St.Petersburg Clinical Research for Specialized Types of Medical Care have developed an intelligent software system for lung cancer diagnostics.

1 Feb 2019

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

Corning Incorporated will showcase advanced 3D cell culture technologies and workflow solutions, and including those for high throughput screening and ADME/toxicology at SLAS 2019.

From Corning Life Sciences 30 Jan 2019

First precision medicine trial in lung cancer expands to include more patients

The Lung Cancer Master Protocol, the first precision medicine trial in lung cancer supported by the National Cancer Institute, part of the National Institutes of Health, is undergoing a major expansion to include patients with all non-small cell lung cancers -- which make up about 85 percent of all lung cancer diagnoses in the U.S.

29 Jan 2019

An engineered virus selectively targets and kills cancer cells

An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.

29 Jan 2019

Lengthened medication time, counseling support can help cancer patients quit smoking

Quitting smoking can significantly improve the effectiveness of cancer treatment, according to the U.S. Surgeon General, yet almost half of cancer patients continue to smoke after they've been diagnosed.

25 Jan 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

Free screening for lung cancer can save money while building healthy relationship with patients

A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical needs they may have in the future.

24 Jan 2019

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

23 Jan 2019

Molecular profiling of precancerous lung lesions could lead to early detection and new treatments

The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.

21 Jan 2019

Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana

A population health study from IUPUI and the Regenstrief Institute has identified striking socioeconomic and racial disparities in health behavior and in the receipt of cancer screening in the 34 Indiana counties with cancer death rates higher than the state's average. Overall, the state of Indiana ranks high -- 11th nationally -- in cancer deaths.

18 Jan 2019

Many cancer patients have undiagnosed hepatitis

A new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.

17 Jan 2019

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.

17 Jan 2019

Study uncovers a protein involved in lung cancer treatment resistance

Lung cancer remains a major cause of mortality across the globe, although we are gaining a deeper understanding of the genetic background behind this disease, including the mutations that promote it.

10 Jan 2019

New findings bring about better understanding of many cancers' metabolic needs

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism.

10 Jan 2019

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

7 Jan 2019

Study finds increase in suicide risk after cancer diagnosis

New research indicates that the risk of suicide increases significantly in the first year following a diagnosis of cancer, and this increase varies by the type of cancer diagnosed.

7 Jan 2019

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.

7 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chance of being alive 5 years later. For patients with stage IV disease, describing cancer that has spread to distant sites beyond the original tumor, that statistic drops to 2 percent.

2 Jan 2019

Lung Cancer News and Research

Latest Lung Cancer News and Research

Graphene could hold key to unlock next generation of early lung cancer diagnosis

Russian researchers create intelligent software system for lung cancer diagnostics

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

First precision medicine trial in lung cancer expands to include more patients

An engineered virus selectively targets and kills cancer cells

Lengthened medication time, counseling support can help cancer patients quit smoking

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Free screening for lung cancer can save money while building healthy relationship with patients

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

Molecular profiling of precancerous lung lesions could lead to early detection and new treatments

Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana

Many cancer patients have undiagnosed hepatitis

QIAGEN receives first companion diagnostic approval in Japan

Study uncovers a protein involved in lung cancer treatment resistance

New findings bring about better understanding of many cancers' metabolic needs

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

Study finds increase in suicide risk after cancer diagnosis

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in